Carol L. Brosgart

Clinical Professor-Medicine, Biostatistics & Epidemiology at UCSF School of Medicine

Carol L. Brosgart

Carol L. Brosgart

Clinical Professor-Medicine, Biostatistics & Epidemiology at UCSF School of Medicine

Overview
Career Highlights

East Bay AIDS Cente

RelSci Relationships

1330

Number of Boards

13

Birthday

1952

Age

69

Relationships
RelSci Relationships are individuals Carol L. Brosgart likely has professional access to. A relationship does not necessarily indicate a personal connection.

Former Vice President, Finance at Matrix Pharmaceutical, Inc.

Relationship likelihood: Strong

Chairman at Ascenta Therapeutics, Inc.

Relationship likelihood: Strong

Managing Director at Vodia Capital LLC

Relationship likelihood: Strong

Managing Partner, Life Sciences Team at Frazier Healthcare Partners

Relationship likelihood: Strong

Co-Founder, Chief Executive Officer at Galmed Pharmaceuticals Ltd.

Relationship likelihood: Strong

Chief Executive Officer at Adverum Biotechnologies, Inc.

Relationship likelihood: Strong

Former President & Chief Executive Officer at Tarveda Therapeutics, Inc.

Relationship likelihood: Strong

Former Senior Executive Vice President & Chief Administrative Officer at Rite Aid Corp.

Relationship likelihood: Strong

Advisory Partner at Domain Associates LLC

Relationship likelihood: Strong

General Counsel at Prevail Therapeutics, Inc.

Relationship likelihood: Strong

Paths to Carol L. Brosgart
Potential Connections via
Relationship Science
You
Carol L. Brosgart
Clinical Professor-Medicine, Biostatistics & Epidemiology at UCSF School of Medicine
Education
B.S. Degree

University of California Berkeley National rankings: In a National Research Council analysis of 212 doctoral programs at American universities, 48 Berkeley programs place among the top 10 nationwide. Faculty awards and honors: There are 8 Nobel Laureates, 32 MacArthur Fellows, and 4 Pulitzer Prize winners among the current faculty. History of UC Berkeley: Historical highlights, arranged by topic, following the campus's development — from UC's founding in 1868 to a turn-of-the-century building boom, a research explosion in the 1930s, the Free Speech Movement of the '60s, and Berkeley's key role today in science and technology revolutions. Timeline of discoveries and contributions by UC Berkeley scholars. Traditions of Cal: Who was the Angel of Death? What's with the "Big C" up there in the hills — and why is it sometimes green? Who wears Oski's jolly bear head and size 54 yellow sweater? Tours and webcams: Check out what's happening on Sproul Plaza, the campus's true heart. See stunning live views of the Bay Area from the Lawrence Hall of Science's perch in the Berkeley hills. Chancellor and administration: Information on Chancellor Robert Birgeneau, Executive Vice Chancellor and Provost George W. Breslauer, and how the university is organized. Organizational charts are included. UC System overview and links: On the campuses, laboratories, and medical centers that comprise UC's public educational system, as well as UC's K-12 partnerships, economic impact, and agriculture and environmental resources.

MD

Consistently ranked among the nation's top medical schools, the UCSF School of Medicine earns its greatest distinction from its outstanding faculty – among them are four Nobel laureates, 75 Institute of Medicine members, 63 American Academy of Arts and Sciences members, 42 National Academy of Sciences members, and 17 Howard Hughes Medical Institute investigators.

Career History
Vice President-Public Health & Policy
1998 - 2009

Since 1987, Gilead Sciences has worked to discover, develop and commercialize medications to advance the care of patients suffering from life-threatening diseases in areas of unmet medical need. In 25 years, Gilead has become a leading biopharmaceutical company with a portfolio of 15 marketed products, a growing pipeline of investigational drugs and approximately 5,000 employees in offices across four continents. Gilead's therapeutic areas of focus include HIV/AIDS, hepatitis, serious respiratory, cardiovascular, and metabolic conditions, cancer and inflammation

Professional
Prior

Alta Bates Medical Center, part of Blue Shield of California, is a company headquartered in Berkeley, CA. The firm operates a physcians office. On 01 Aug 11 Brown & Toland Physicians, a subsidiary of Blue Shield of California since November 2020, acquired Alta Bates Medical Center.

Chief Medical Officer
2011 - 2011

Alios BioPharma, Inc. operates as a clinical stage biopharmaceutical company which develops novel antiviral therapies for the treatment of respiratory diseases. It also develops proprietary chemical libraries of novel nucleosides, nucleoside analogs and non-nucleosides as potential therapeutics for viral infections including RSV, influenza, rhinovirus and emerging viral diseases. The firm offers VX-135, a uridine nucleotide analog for the treatment of chronic hepatitis C. The company was founded by Leonid N. Beigelman, Lawrence M. Blatt and John R. Donovan in 2008 and is headquartered in San Francisco, CA.

Boards & Committees
Director
2019 - Current

Enochian Biosciences, Inc. engages in the development of genetically modified cellular and immune-therapy technologies for treatment of infectious diseases and cancer. Its pipeline consists of ENOB-HV-01, ENOB- HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21. The company was founded by Rene Sindlev on January 18, 2011 and is headquartered in Los Angeles, CA.

Member, Board of Directors
2018 - Current

Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development comprise of vaccine for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.

Independent Director
2017 - Current

Galmed Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of oral therapy for the treatment of non-alcoholic steato-hepatitis (NASH). Its product candidate, Aramchol, is a synthetic fatty acid-bile acid conjugate molecule for the oral treatment of NASH in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company was founded by Allen Baharaff and Tuvia Gilat in 2000 and is headquartered in Tel Aviv, Israel.

Member, Board of Directors
Current

THE MISSION OF THE HEPATITIS B FOUNDATION IS TO FIND A CURE FOR HEPATITIS B AND IMPROVE THE QUALITY OF LIFE FOR THOSE AFFECTED WORLDWIDE THROUGH RESEARCH, EDUCATION AND PATIENT ADVOCACY.

Member, Board of Directors
Current

PROVIDE BERKELEY YOUTH FROM LOWER-INCOME FAMILIES WITH SCHOLARSHIPS AND OTHER SUPPORTS INSTRUMENTAL TO SUCCESS IN COLLEGE AND BEYOND.

Director
2008 - Prior

The San Francisco Aids Foundation is an American private company located in San Francisco, CA, that provides education, advocacy and direct services for HIV prevention and care.The company says this about itself: No city experienced epidemic levels of HIV faster than San Francisco. San Francisco AIDS Foundation works to end the epidemic where it first took hold, and eventually everywhere. Established in 1982, our mission is to radically reduce new infections in San Francisco. Through education, advocacy, and direct services for prevention and care, we are confronting HIV in communities most vulnerable to the disease.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$1,000 - $2,499
2018

American Liver Foundation engages in facilitating, advocating and promoting education, support, and research for the prevention, treatment, and cure of liver disease. It educates patients, policymakers and the public and provides grants to early-career researchers to help find a cure for all liver diseases. The company was founded in 1976 and is headquartered in New York, NY.

$1,000 - $2,499
2018

The San Francisco Aids Foundation is an American private company located in San Francisco, CA, that provides education, advocacy and direct services for HIV prevention and care.The company says this about itself: No city experienced epidemic levels of HIV faster than San Francisco. San Francisco AIDS Foundation works to end the epidemic where it first took hold, and eventually everywhere. Established in 1982, our mission is to radically reduce new infections in San Francisco. Through education, advocacy, and direct services for prevention and care, we are confronting HIV in communities most vulnerable to the disease.

$1,000 - $2,499
2018

THE MISSION OF THE HEPATITIS B FOUNDATION IS TO FIND A CURE FOR HEPATITIS B AND IMPROVE THE QUALITY OF LIFE FOR THOSE AFFECTED WORLDWIDE THROUGH RESEARCH, EDUCATION AND PATIENT ADVOCACY.

Political Donations
$20
2020

ActBlue is an online toolset that makes it easy for donors to connect with the candidates and causes they support. At ActBlue, the objective is to democratize power by putting powerful fundraising tools in the hands of grassroots donors across the United States.

$10
2020

ActBlue is an online toolset that makes it easy for donors to connect with the candidates and causes they support. At ActBlue, the objective is to democratize power by putting powerful fundraising tools in the hands of grassroots donors across the United States.

$100
2020

ActBlue is an online toolset that makes it easy for donors to connect with the candidates and causes they support. At ActBlue, the objective is to democratize power by putting powerful fundraising tools in the hands of grassroots donors across the United States.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Carol L. Brosgart. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Carol L. Brosgart's profile does not indicate a business or promotional relationship of any kind between RelSci and Carol L. Brosgart.